MicroPort Endovascular MedTech Ltd Total Liabilities

Latest as of June 2026: CN¥680.21 Million CNY ≈ $99.54 Million USD

MicroPort Endovascular MedTech Ltd total liabilities. Based on the latest financial reports, MicroPort Endovascular MedTech Ltd (688016) has total liabilities worth CN¥680.21 Million CNY (≈ $99.54 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 688016 financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of MicroPort Endovascular MedTech Ltd (2016–2025)

Total liabilities of MicroPort Endovascular MedTech Ltd from 2016 to 2025. This chart illustrates how MicroPort Endovascular MedTech Ltd's total liabilities have evolved over time, based on quarterly financial data.

MicroPort Endovascular MedTech Ltd Competitors by Total Liabilities

The table below lists competitors of MicroPort Endovascular MedTech Ltd ranked by their total liabilities.

Company Country Total Liabilities
Indegene Ltd
NSE:INDGN
India Rs14.82 Billion
Global Net Lease, Inc.
NYSE:GNL
USA $2.56 Billion
Partner
TA:PTNR
Israel ILA2.17 Billion
Antin IP SA
PA:ANTIN
France €127.37 Million
Zhejiang CONBA Pharmaceutical Co Ltd
SHG:600572
China CN¥2.85 Billion
CleanSpark Inc
NASDAQ:CLSK
USA $1.94 Billion
GigaCloud Technology Inc Class A Ordinary Shares
NASDAQ:GCT
USA $716.66 Million
ManpowerGroup Inc
NYSE:MAN
USA $6.33 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down MicroPort Endovascular MedTech Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see MicroPort Endovascular MedTech Ltd assets under control.

Liquidity & Leverage Metrics

MicroPort Endovascular MedTech Ltd Total Liabilities Ratios Explained

MicroPort Endovascular MedTech Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 5.42 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.16 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.14 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how MicroPort Endovascular MedTech Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for MicroPort Endovascular MedTech Ltd (2016–2025)

The table below shows the annual total liabilities of MicroPort Endovascular MedTech Ltd from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥-3.98 Billion
≈ $-582.73 Million
-948.88%
2024-12-31 CN¥469.13 Million
≈ $68.65 Million
+22.60%
2023-12-31 CN¥382.63 Million
≈ $55.99 Million
+51.54%
2022-12-31 CN¥252.49 Million
≈ $36.95 Million
+9.08%
2021-12-31 CN¥231.47 Million
≈ $33.87 Million
+62.90%
2020-12-31 CN¥142.09 Million
≈ $20.79 Million
+58.34%
2019-12-31 CN¥89.74 Million
≈ $13.13 Million
+70.41%
2018-12-31 CN¥52.66 Million
≈ $7.71 Million
+45.29%
2017-12-31 CN¥36.24 Million
≈ $5.30 Million
-44.43%
2016-12-31 CN¥65.22 Million
≈ $9.54 Million
--

About MicroPort Endovascular MedTech Ltd

SHG:688016 China Medical Devices
Market Cap
$1.58 Billion
CN¥10.82 Billion CNY
Market Cap Rank
#6773 Global
#1361 in China
Share Price
CN¥87.78
Change (1 day)
-1.25%
52-Week Range
CN¥82.40 - CN¥111.80
All Time High
CN¥443.37
About

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, sale, and services of aortic, peripheral vascular, and tumor intervention devices in China and internationally. The company offers Fontus, a branched stent graft system in surgical operation; CRONUS, a stent graft system in surgical operation; Hector, a multi-branch thoracic stent graft syste… Read more